Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC Diagnosis

Affiliations

• ¹ Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (S.A.M., B.A., B.M., C.T., A.G., R.T.C., H.C., C.A.J.).
• ² Department of Cardiology, University Medical Center Utrecht, the Netherlands. (S.A.M., M.I.F.J.O., A.S.J.M.t.R.).
• ³ ERN GUARD-Heart (S.A.M., A.S.A., S.-C.Y., M.I.F.J.O., J.P.v.T., A.S.J.M.t.R.).
• ⁴ Department of Cardiology, University Medical Centre Groningen, the Netherlands (M.G.P.J.C.).
• ⁵ Department of Cardiology, Amsterdam UMC location AMC, University of Amsterdam, the Netherlands (A.S.A.).
• ⁶ Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC, Rotterdam (S.-C.Y.).
• ⁷ Cardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, QC, Canada (J.C.-T.).
• ⁸ Department of Genetics, University Medical Center Utrecht, the Netherlands. (J.P.v.T.).